Agreement between Xpert and AmpFire tests for high-risk human papillomavirus among HIV-positive women in Rwanda

Background: High-risk human papillomavirus (hrHPV) may cause more than 99% of cervical cancers worldwide. Little is known about performance differences in tests for hrHPV. Objective: This study analysed agreement for detection of hrHPV between the established, clinically validated Xpert HPV assay a...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anthere Murangwa, Kanan T. Desai, Julia C. Gage, Gad Murenzi, Patrick Tuyisenge, Faustin Kanyabwisha, Aimable Musafili, Gallican Kubwimana, Leon Mutesa, Kathryn Anastos, Hae-Young Kim, Philip E. Castle
Format:	Artigo
Idioma:	Inglês
Publicat:	AOSIS 2022-10-01
Col·lecció:	African Journal of Laboratory Medicine
Matèries:	xpert hpv assay ampfire hpv genotyping assay high-risk human papillomavirus types women living with hiv cervical cancer screening
Accés en línia:	https://ajlmonline.org/index.php/ajlm/article/view/1827
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!